| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2015 | Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen | Zhang, Tian-Ying; Yuan, Quan; Zhao, Jing-Hua; Zhang, Ya-Li; Yuan, Lun-Zhi; Lan, Ying; Lo, Yu-Chieh; Sun, Cheng-Pu ; Wu, Chang-Ru; Zhang, Jun-Fang; Zhang, Ying; Cao, Jia-Li; Guo, Xue-Ran; Liu, Xuan; Mo, Xiao-Bing; Luo, Wen-Xin; Cheng, Tong; Chen, Yi-Xin; Tao, Mi-Hua ; Shih, James WK; Zhao, Qin-Jian; Zhang, Jun; Chen, Pei-Jer; Yuan, Y Adam; Xia, Ning-Shao | Gut 65(4), 658-671 | | | |
| 2011 | Risk score for development of HCC: ready for use in practice? - Authors' reply | Yang, Hwai-I; Yuen, Man-Fung; Chan, Henry Lik-Yuen; Han, Kwang-Hyub; Chen, Pei-Jer; Kim, Do-Young; Ahn, Sang-Hoon; Chen, Chien-Jen; Wong, Vincent Wai-Sun; Seto, Wai-Kay; REACH-B Working Group | Lancet Oncol 12:518-519 | | | |
| 2021 | Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses | Lin, Pin-Hung; Liang, Chieh-Yu; Yao, Bing-Yu; Chen, Hui-Wen; Pan, Ching-Fu; Wu, Li-Ling; Lin, Yi-Hsuan; Hsu, Yu-Sung; Liu, Yu-Han; Chen, Pei-Jer; Hu, Che-Ming Jack ; Yang, Hung-Chih | Molecular Therapy - Methods & Clinical Development 21, 299-314 | | | |
